Indoco Remedies Limited (INDOCO) — Announcement Announcement
📢 Key Event
Company confirmed SEBI Regulation 74(5) compliance for Q1 2026
💡 Investor Takeaway
Shareholders can verify regulatory compliance without affecting financial performance.
Indoco Remedies Limited confirmed compliance with SEBI's Regulation 74(5) for the quarter ended March 31, 2026, via a certificate from MUFG Intime India Private Limited, validating dematerialisation and listing status of securities.
📄 View Original Announcement (PDF)
About Indoco Remedies Limited (INDOCO)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹2,075.91 Cr
P/E: -142.3
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.